The Immunocompromised Host: Immune Alterations in Splenectomized Patients and Clinical Implications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|24|1918-1923

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.24, 2003-09, pp. : 1918-1923

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune responses to BK and JC viruses in immunocompromised patients

By Lacey Simon F   Zhou Wendi  

Future Virology, Vol. 2, Iss. 3, 2007-05 ,pp. : 255-266

Future Medicine

Access to resources Recommend Favorite

Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised host

By Freeman Richard B  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 2007-2016

Informa Healthcare

Access to resources Recommend Favorite

Cytomegalovirus treatment options in immunocompromised patients

By Sharland Mike   Khare Milind D  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 8, 2001-08 ,pp. : 1247-1257

Informa Healthcare

Access to resources Recommend Favorite

Influenza in immunocompromised patients: considerations for therapy

By Antón Andrés   Pumarola Tomás  

Future Virology, Vol. 6, Iss. 7, 2011-07 ,pp. : 855-868

Future Medicine

Access to resources Recommend Favorite

Cytomegalovirus Infections in Non-Immunocompromised and Immunocompromised Patients in the Intensive Care Unit

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 11, Iss. 4, 2011-08 ,pp. : 354-364

Bentham Science Publishers

Access to resources Recommend Favorite